BioPorto

Share Issue/Capital Change • Sep 4, 2015

August 31, 2015, The Board of Directors of BioPorto A/S (BioPorto) decided to
partially exercise the authorization in the Company Articles article 16b to
make a direct placement to a limited number of institutional and financial
investors, cf. company announcement no. 15 of August 31, 2015. As announced in
company announcement no. 16 of August 31, 2015, the rights issue was fully
subscribed.

Completion of the rights issue

BioPorto A/S has now received the full subscription amount, and today the
company has procured that the capital increase of in total nominally DKK
11,724,750 has been registered with the Danish Business Authority.

BioPorto A/S’ gross proceeds from the rights issue amount to DKK 28.1 million.
The aggregate net proceeds amount to DKK 26.6 million after deduction of costs
for the completion of the rights issue.

Admission to trading and official listing

The new shares will as soon as possible be admitted to trading and official
listing on Nasdaq Copenhagen A/S under the ISIN code of the company’s existing
shares (ISIN DK0011048619), which is expected to take place on September 10,
2015.

Share capital after the rights issue

As a result of the rights issue, BioPorto A/S’ share capital has been increased
by nominally DKK 11,724,750. Accordingly, the total share capital of BioPorto
A/S now amounts to DKK 129,598,960 divided into 129,598,960 shares of nominally
DKK 1 each, equivalent to 129,598,960 votes. BioPorto A/S’ articles of
association have been updated accordingly and are available on the company’s
website.

For further information please contact:

Peter Mørch Eriksen, CEO

Christina Thomsen, Investor relations

Tel.: 45 29 00 00, e-mail investor@bioporto.com